Timothy M. Pawlik
Deputy Editor at JAMA Surgery
Chair @OhioStateSurg, surgeon-in-chief @OSUWexMed and professor @OhioStateMed. Sharing news from DoS. Boston sports fan. Tweets are my own. #OhioStateSurg
Articles
-
2 months ago |
ejso.com | Timothy M. Pawlik |Miho Akabane |Jun Kawashima |Abdullah Altaf |Selamawit Woldesenbet |Federico Aucejo | +9 more
Key wordsGallbladder carcinoma (GBC)DiagnosisTumor locationPeritonealSizeImagingGet full text accessLog in, subscribe or purchase for full access. References1. Neculoiu, D. ... The Many Hidden Faces of Gallbladder Carcinoma on CT and MRI Imaging-From A to ZDiagnostics (Basel). 2024; 142. Wernberg, J.A. ∙ Lucarelli, D.D.Gallbladder cancerSurgical Clinics. 2014; 94:343-3603. Hundal, R. ∙ Shaffer, E.A.Gallbladder cancer: epidemiology and outcomeClinical epidemiology. 2014; 99-1094. Mallick, S. ...
-
2 months ago |
jamanetwork.com | Diamantis I. Tsilimigras |Timothy M. Pawlik
Molecular Testing and Targeted Therapies in Hepatobiliary Cancers: A Review Podcast (12:47) 0:00 / 0:00 Abstract Importance Hepatobiliary cancers are heterogeneous and molecularly complex.
-
2 months ago |
jamanetwork.com | Diamantis I. Tsilimigras |Timothy M. Pawlik
Importance Hepatobiliary cancers are heterogeneous and molecularly complex. Recent advances in next-generation sequencing (NGS) have enhanced the understanding of their molecular landscape and enabled deployment of biomarker-based gene- and immune-targeted therapies. This review examines the role of molecular testing and targeted therapies in these malignant neoplasms. Observations Patients with hepatobiliary cancers have poor outcomes.
-
2 months ago |
jamanetwork.com | Rachel A. Greenup |Danny Chu |Timothy M. Pawlik
In the US, individuals with commercial insurance or Medicare-based plans make up approximately 55% and 20% of the population, respectively.1 As a result, administrative and billing data sources are collected by health care organizations, institutions, or government agencies to manage the administrative and financial aspects of health care services. These datasets robustly characterize billable services for individuals receiving inpatient and outpatient medical care and rely on billable codes.
-
Feb 19, 2025 |
ejso.com | Timothy M. Pawlik
Keywords Colorectal cancer Gene signature Overall survival Therapeutic target Machine learning INTRODUCTION Despite advancements in the diagnosis and treatment of patients with colorectal cancer (CRC), mortality remains relatively high.1 In fact, up to 50% of patients develop metastatic CRC (mCRC) at some point in the course of their disease with a subsequent 5-year survival of only 15-40%.2,3 Traditionally, clinicopathological predictors, such as tumor size as well as Tumor/Node/Metastasis...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 7K
- Tweets
- 2K
- DMs Open
- No
RT @OhioStateSurg: Big news! #OhioStateSurg Dr. Alex Blair has been awarded @theNCI's Paul Calabresi K12 Award to advance research on STING…
Thrilled Andrew Loudon, MD, will join @OhioStateSurg in Div of Trauma, Critical Care & Burn. Dr. Loudon has experience as a Trauma ICU Director, as well as Assoc PD & simulation director for his current general surgery residency program. Another great addition to our DoS #TEAM! https://t.co/8bVroJUL9N
Congrats @OhioStateSurg med students, residents, fellows, & post-doc’s who presented at 30th annual DoS Research Day 🔬! Great science! Also big thank you to our very own Dr. Ginny Bumgardner as our 50th Zollinger lecture & architect of our surgeon-scientist training program. 🙌 https://t.co/xirDvIhUTy
